Dual role of Th17 cells in Crohn's disease

被引:5
作者
Karczewski, Jacek [1 ]
Mazur, Maciej [2 ]
Karczewski, Marek [1 ]
机构
[1] Poznan Univ Med Sci, PL-61701 Poznan, Poland
[2] Solumed, Res Unit, Poznan, Poland
关键词
IBD; Crohn's disease; Th17; IL-17; Th1/Th2/Th17; REGULATORY T-CELLS; TGF-BETA; T(H)17 CELLS; COLITIS; CYTOKINES; IL-17; DIFFERENTIATION; INTERLEUKIN-12; PATHOGENESIS; INFLAMMATION;
D O I
10.5114/ceji.2012.30808
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Crohn's disease (CD) is a chronic relapsing, destructive inflammatory disease of the gastrointestinal (GI) tract, the cause of which remains still unknown. Accumulating evidence suggests that CD results from the imbalance between pro- and anti-inflammatory agents and the overactivity of T helper (Th)I. It seems that major cause of GI inflammation is an IL-12-driven ThI response, which results in the generation of IFN-gamma, the key inflammatory mediator Recently, however, much attention has also been given to the possible involvement of Th17 cells in the pathogenesis of CD. This mini-review is aimed to summarize the current knowledge on the dual role of Th17 cells in CD.
引用
收藏
页码:286 / 289
页数:4
相关论文
共 38 条
[1]   InterIeukin-23/Th17 Pathways and Inflammatory Bowel Disease [J].
Abraham, Clara ;
Cho, Judy .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (07) :1090-1100
[2]   Regulatory T cells: Peace keepers in the gut [J].
Allez, M ;
Mayer, L .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) :666-676
[3]   ATP drives lamina propria TH17 cell differentiation [J].
Atarashi, Koji ;
Nishimura, Junichi ;
Shima, Tatsuichiro ;
Umesaki, Yoshinori ;
Yamamoto, Masahiro ;
Onoue, Masaharu ;
Yagita, Hideo ;
Ishii, Naoto ;
Evans, Richard ;
Honda, Kenya ;
Takeda, Kiyoshi .
NATURE, 2008, 455 (7214) :808-U10
[4]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[5]   Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease [J].
Brand, S. .
GUT, 2009, 58 (08) :1152-1167
[6]   Conventional Medical Management of Inflammatory Bowel Disease [J].
Burger, Daniel ;
Travis, Simon .
GASTROENTEROLOGY, 2011, 140 (06) :1827-U173
[7]   Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial [J].
Colombel, Jean-Frederic ;
Sandborn, William J. ;
Rutgeerts, Paul ;
Enns, Robert ;
Hanauer, Stephen B. ;
Panaccione, Remo ;
Schreiber, Stefan ;
Byczkowski, Dan ;
Li, Ju ;
Kent, Jeffrey D. ;
Pollack, Paul F. .
GASTROENTEROLOGY, 2007, 132 (01) :52-65
[8]   Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice [J].
Elson, Charles O. ;
Cong, Yingzi ;
Weaver, Casey T. ;
Schoeb, Trenton R. ;
McClanahan, Terrill K. ;
Fick, Robert B. ;
Kastelein, Robert A. .
GASTROENTEROLOGY, 2007, 132 (07) :2359-2370
[9]   Control of TH17 cells occurs in the small intestine [J].
Esplugues, Enric ;
Huber, Samuel ;
Gagliani, Nicola ;
Hauser, Anja E. ;
Town, Terrence ;
Wan, Yisong Y. ;
O'Connor, William, Jr. ;
Rongvaux, Anthony ;
Van Rooijen, Nico ;
Haberman, Ann M. ;
Iwakura, Yoichiro ;
Kuchroo, Vijay K. ;
Kolls, Jay K. ;
Bluestone, Jeffrey A. ;
Herold, Kevan C. ;
Flavell, Richard A. .
NATURE, 2011, 475 (7357) :514-U114
[10]  
Fuss IJ, 1996, J IMMUNOL, V157, P1261